Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Annual Information Update

12 Jul 2012 17:01

RNS Number : 5778H
Maven Income & Growth VCT 4 PLC
12 July 2012
 



MAVEN INCOME AND GROWTH VCT 4 PLC

 

ANNUAL INFORMATION UPDATE

 

Pursuant to the requirements of Prospectus Rule 5.2, the following summarises the information that has been published by the Company since 24 May 2011.

 

Announcements listed as published on the London Stock Exchange have been published via a Regulatory Information Service and can be found on http://londonstockexchange.com/. (The relevant code for the Company is 'ORT'.)

 

Copies of documents at Companies House, including Reports and Accounts, can be obtained from Companies House or via the Manager at hhtp://www.mavencp.com. Reports and Accounts can also be inspected at the National Storage Mechanism at www.hemscott.com/nsm.do.

 

Some of the information referred to below was provided as at a specific date and may now be out of date.

 

Announcements to the London Stock Exchange

 

·; 17 May 13:02

·; Result of AGM  

·; 17 May 09:31

·; Interim Management Statement  

·; -03 May 17:36

·; Transaction in Own Shares  

·; 02 May 16:12

·; Director/PDMR Shareholding  

·; 02 May 15:59

·; Director/PDMR Shareholding  

·; -02 May 15:30

·; Transaction in Own Shares  

·; 26 Apr 14:24

·; Transaction in Own Shares  

·; 20 Apr 13:11

·; Issue of Equity

·; 18 Apr 12:26

·; Annual Financial Report - Replacement  

·; 10 Apr 09:59

·; Issue of Equity  

·; 08 Mar 16:02

·; Director/PDMR Shareholding  

·; 02 Mar 09:39

·; Issue of Equity  

·; 07 Dec 16:20

·; Issue of Equity  

·; 22 Nov 16:45

·; Transaction in Own Shares  

·; 17 Nov 16:55

·; Transaction in Own Shares  

·; 16 Nov 15:09

·; Interim Management Statement  

·; 29 Sep 17:04

·; Transaction in Own Shares  

·; 15 Aug 15:34

·; Half Yearly Report  

·; 01 Jul 07:00

·; Transaction in Own Shares  

·; 29 Jun 14:44

·; Transaction in Own Shares  

29 Jun 14:43

Transaction in Own Shares

14 Jun 10:51

Statement re cancellation of share premium

 

 

 

 

 

Documents filed at Companies House

 

Type Date Description

AD01

18/06/2012

REGISTERED OFFICE CHANGED ON 18/06/2012 FROM SUTHERLAND HOUSE, 149 ST VINCENT STREET GLASGOW G2 5NW

 

AA

31/05/2012

FULL ACCOUNTS MADE UP TO 31/12/11

 

RES10

25/05/2012

AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES

 

CH01

11/01/2012

DIRECTOR'S CHANGE OF PARTICULARS / STEVEN SCOTT / 04/01/2012

 

SH03

27/10/2011

RETURN OF PURCHASE OF OWN SHARES28/09/11 TREASURY CAPITAL GBP 23672.8

 

AR01

15/09/2011

26/08/11 FULL LIST

 

SH03

22/07/2011

RETURN OF PURCHASE OF OWN SHARES

 

SH03

22/07/2011

RETURN OF PURCHASE OF OWN SHARES

 

SH19

13/06/2011

13/06/11 STATEMENT OF CAPITAL GBP 1369081.1

 

OC138

13/06/2011

REDUCTION OF ISS CAPITAL AND MINUTE (OC)

 

CERT21

13/06/2011

REDUCTION OF SHARE PREMIUM

 

 

 

Maven Capital Partners UK LLP

Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIUGGUUUMUPPGQP
Date   Source Headline
20th May 202610:12 amRNSAdmission of Further Securities to Trading
15th May 202610:45 amRNSDirector/PDMR Shareholding
15th May 202610:41 amRNSIssue of Equity - Dividend Investment Scheme
14th May 20265:22 pmRNSTransaction in Own Shares
12th May 20263:37 pmRNSUnaudited NAV - Dividend Investment Scheme
7th May 20261:45 pmRNSResult of AGM
30th Apr 202610:58 amRNSAdmission of Further Securities to Trading
29th Apr 202612:29 pmRNSIssue of Equity
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:27 amRNSAdmission of Further Securities to Trading
14th Apr 202611:09 amRNSIssue of Equity
10th Apr 202612:02 pmRNSUnaudited Net Asset Value
8th Apr 20269:33 amRNSAdmission of Further Securities to Trading
25th Mar 20263:51 pmRNSTransaction in Own Shares
25th Mar 202610:55 amRNSAdmission of Further Securities to Trading
24th Mar 202612:11 pmRNSIssue of Equity
19th Mar 20264:21 pmRNSUnaudited NAV and Proposed Final Dividend
18th Feb 20264:58 pmRNSAdmission of Further Securities to Trading
17th Feb 202611:07 amRNSDirector/PDMR Shareholding
17th Feb 202611:07 amRNSDirector/PDMR Shareholding
17th Feb 202610:54 amRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
21st Jan 202611:07 amRNSAdmission of Further Securities to Trading
20th Jan 20262:05 pmRNSAdmission of Further Securities to Trading
16th Jan 20269:52 amRNSDirector/PDMR Shareholding
16th Jan 20269:44 amRNSIssue of Equity
15th Jan 202610:36 amRNSDirector/PDMR Shareholding
15th Jan 202610:35 amRNSDirector/PDMR Shareholding
15th Jan 20269:55 amRNSIssue of Equity
14th Jan 20262:39 pmRNSUnaudited NAV - Dividend Investment Scheme
13th Jan 202612:10 pmRNSUnaudited Net Asset Value
4th Dec 202510:35 amRNSSecond Interim Dividend
18th Nov 20253:48 pmRNSTransaction in Own Shares
14th Nov 20259:31 amRNSNet Asset Value(s)
13th Nov 20254:53 pmRNSResult of General Meeting
2nd Oct 20254:42 pmRNSPublication of a Prospectus
29th Aug 20257:00 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSIssue of Equity
29th Aug 20257:00 amRNSHalf-year Report
20th Aug 20252:14 pmRNSStatement re Dividend Investment Scheme
31st Jul 20254:42 pmRNSTransaction in Own Shares
16th Jul 202510:18 amRNSStatement re Unaudited NAV and Interim Dividend
16th Jul 20257:08 amRNSStatement re Offer for Subscription
21st May 20254:44 pmRNSTransaction in Own Shares
16th May 20259:30 amRNSDirector/PDMR Shareholding
16th May 20259:26 amRNSIssue of Equity - Dividend Investment Scheme
9th May 20251:53 pmRNSStatement re Dividend Investment Scheme
9th May 202510:03 amRNSNet Asset Value(s)
8th May 20251:43 pmRNSResult of AGM
6th May 202511:55 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.